BlueCrest Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-68,434	Closed	-$948K	–	936
2017 Q2	$948K	Buy	+68,434	New	+$948K	0.04%	453